| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |